$KYTX 4 SEC Filings

Filed On	Filing
29 May 2026	Form 4: Clark Ian T, Director Received 5,093 shares as a grant or award · Granted 20,582 Stock Option (right to buy)
29 May 2026	Form 4: Cohen Fred E, Director Received 5,093 shares as a grant or award · Granted 20,582 Stock Option (right to buy)
29 May 2026	Form 4: Seidenberg Beth C, Director Received 5,093 shares as a grant or award · Granted 20,582 Stock Option (right to buy)
29 May 2026	Form 4: Shaw Christi, Director Gave up 4,194 shares to cover exercise price or tax ($36K)
29 May 2026	Form 4: Aktar Mert, Director Received 5,093 shares as a grant or award · Granted 20,582 Stock Option (right to buy)
20 May 2026	Form 4: Martini Gregory S., Chief Financial Officer Granted 325,000 Stock Option (right to buy)
06 May 2026	Form 4: Dac Nadia, Chief Commercial Officer Granted 300,000 Stock Option (right to buy)
17 Mar 2026	Form 4: Grasso Marc, Chief Financial Officer Received 10,000 shares as a grant or award · Granted 65,000 Stock Option (right to buy)
17 Mar 2026	Form 4: Biddle Warner Weston, Director Received 58,000 shares as a grant or award · Granted 350,000 Stock Option (right to buy)
17 Mar 2026	Form 4: Gehchan Naji, See Remarks Received 18,000 shares as a grant or award · Granted 105,000 Stock Option (right to buy)
04 Mar 2026	Form 4: Miller Andrew Craig, Director Received 11,006 shares as a grant or award · Granted 42,945 Stock Option (right to buy)
26 Feb 2026	Form 4: Emany Sravan Kumar, Director Received 11,006 shares as a grant or award · Granted 42,945 Stock Option (right to buy)
11 Feb 2026	Form 4: Pujols Mayobanex, Chief Technology Officer Granted 300,000 Stock Option (right to buy)
14 Jan 2026	Form 4: Shaw Christi, Director Received 54,301 shares as a grant or award · Granted 185,000 Stock Option (right to buy)
22 Dec 2025	Form 4: Seidenberg Beth C, Director Bought 133,333 shares ($1M)
22 Dec 2025	Form 4: Westlake BioPartners Opportunity Fund I, L.p., 10% owner and 3 others Bought 133,333 shares ($1M)
17 Dec 2025	Form 4: Walker Karen Marie, Chief Technology Officer Received 23,998 shares by exercise or conversion ($116K) · Sold 23,998 shares ($293K)
01 Jul 2025	Form 4: Grasso Marc, Chief Financial Officer Disposed of 450,000 Stock Option (right to buy) (Grant/Award Acquisition)
02 Jun 2025	Form 4: Shaw Christi, Director Received 16,634 shares as a grant or award · Granted 65,351 Stock Option (right to buy)
02 Jun 2025	Form 4: Seidenberg Beth C, Director Received 16,634 shares as a grant or award · Granted 65,351 Stock Option (right to buy)

Comments